EGF-R signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion by Mariotti, Agnese et al.
 

 
 The Rockefeller University Press, 0021-9525/2001/10/447/11 $5.00
The Journal of Cell Biology, Volume 155, Number 3, October 29, 2001 447–457
http://www.jcb.org/cgi/doi/10.1083/jcb.200105017
 
JCB
 
Article
 
447
 
EGF-R signaling through Fyn kinase disrupts the 
 
function of integrin 
 
 
 
6
 
 
 
4 at hemidesmosomes: role in 
epithelial cell migration and carcinoma invasion
 
Agnese Mariotti,
 
1
 
 Paul A. Kedeshian,
 
1,2
 
 Michael Dans,
 
1
 
 Anna Maria Curatola,
 
3 
 
Laurent Gagnoux-Palacios,
 
1
 
and Filippo G. Giancotti
 
1
 
1
 
Cellular Biochemistry and Biophysics Program and 
 
2
 
Head and Neck Service, Department of Surgery, 
Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
 
3
 
Department of Pediatrics, New York University School of Medicine, New York, New York 10016
 
e have examined the mechanism and functional
signiﬁcance of hemidesmosome disassembly
during normal epithelial cell migration and
squamous carcinoma invasion. Our ﬁndings indicate
that a fraction of EGF receptor (EGF-R) combines with
the hemidesmosomal integrin 
 
 
 
6
 
 
 
4 in both normal and
neoplastic keratinocytes. Activation of the EGF-R causes
 
tyrosine phosphorylation of the 
 
 
 
4 cytoplasmic domain
and disruption of hemidesmosomes. The Src family kinase
inhibitors PP1 and PP2 prevent tyrosine phosphorylation of
 
 
 
4 and disassembly of hemidesmosomes without interfering
with the activation of EGF-R. Coimmunoprecipitation
experiments indicate that Fyn and, to a lesser extent, Yes
 
combine with 
 
 
 
6
 
 
 
4. By contrast, Src and Lck do not associate
W
 
with 
 
 
 
6
 
 
 
4 to a signiﬁcant extent. A dominant negative form
of Fyn, but not Src, prevents tyrosine phosphorylation of 
 
 
 
4
and disassembly of hemidesmosomes. These observations
suggest that the EGF-R causes disassembly of hemidesmo-
somes by activating Fyn, which in turn phosphorylates the
 
 
 
4 cytoplasmic domain. Neoplastic cells expressing dominant
 
negative Fyn display increased hemidesmosomes and
migrate poorly in vitro in response to EGF. Furthermore,
dominant negative Fyn decreases the ability of squamous
carcinoma cells to invade through Matrigel in vitro and to
form lung metastases following intravenous injection in
nude mice. These results suggest that disruption of hemides-
mosomes mediated by Fyn is a prerequisite for normal
keratinocyte migration and squamous carcinoma invasion.
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Introduction
 
Normal cell migration and tumor invasion are both driven by
changes in actin dynamics and integrin function. In essence,
cells first extend actin-rich protrusions, named filopodia and
lamellipodia, toward the direction of movement. Integrin-
dependent adhesions, such as focal complexes and adhesion
plaques, are then nucleated at the leading edge to derive the
traction necessary for movement. Finally, cells pull forward
by contracting the actin cytoskeleton and releasing integrin
attachments at the rear end (Horwitz and Parsons, 1999).
Whereas 
 
 
 
1 and 
 
 
 
v integrins are connected to the actin
cytoskeleton and their role in cell migration and invasion is
well established, the function of the 
 
 
 
6
 
 
 
4 integrin and
associated keratin cytoskeleton in these processes is poorly
understood.
The 
 
 
 
6
 
 
 
4 integrin is a laminin 5 receptor expressed in epi-
thelial, Schwann, endothelial, and double-negative T cells
(Giancotti, 1996; Borradori and Sonnenberg, 1999). In the
basal cells of stratified and transitional epithelia, 
 
 
 
6
 
 
 
4 is con-
centrated at hemidesmosomes, adhesive junctions connected
to the keratin cytoskeleton (Carter et al., 1990; Sonnenberg
et al., 1991). In addition to 
 
 
 
6
 
 
 
4, hemidesmosomes contain
the transmembrane element bullous pemphigoid antigen
(BPAG)*-2, which is thought to interact with an unknown
basement membrane component. Inside the cell, 
 
 
 
6
 
 
 
4 and
BPAG-2 interact as a functional unit with two plakins, plec-
 
*Abbreviations used in this paper: BPAG, bullous pemphigoid antigen;
ERK, extracellular signal-regulated kinase; FAK, focal adhesion kinase;
ITAM, immunoreceptor tyrosine-based activation motif; PI-3K, phos-
phatidylinositol-3 kinase. 
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tin/HD-1 and BPAG-1, that form the inner plaque of
hemidesmosomes and link to the keratin cytoskeleton (Rez-
niczek et al., 1998; Schaapveld et al., 1998; Geerts et al.,
1999; Hopkinson and Jones, 2000). Although genetic analy-
ses suggest that these proteins are essential to build the core
structure of hemidesmosomes (Guo et al., 1995; McGrath et
al., 1995; Dowling et al., 1996; Smith et al., 1996; van der
Neut et al., 1996; Andra et al., 1997; Ryan et al., 1999), they
are not sufficient to account for the dynamic regulation of
these junctions. In particular, it is known that the hemides-
mosomes are disassembled during keratinocyte migration,
presumably in response to activation of the EGF receptor
(EGF-R) (Gipson et al., 1993; Mainiero et al., 1996). In ad-
dition, squamous carcinoma cells often lack hemidesmo-
somes in vivo (Schenk, 1979). Because hemidesmosomes me-
diate stable adhesion, their disruption may be a prerequisite
for both normal migration and cancer invasion. The mecha-
nisms and regulatory components mediating the disassembly
of hemidesmosomes are poorly understood.
The 
 
 
 
6
 
 
 
4 integrin is characterized by the uniquely large
cytoplasmic domain of its 
 
 
 
4 subunit, which appears to in-
teract directly with both BPAG-2 and plectin/HD-1, and
which is necessary for the assembly of hemidesmosomes
(Murgia et al., 1998; Schaapveld et al., 1998). Recent studies
have revealed that 
 
 
 
6
 
 
 
4 has also a signaling function. The
integrin is associated with a tyrosine kinase and becomes
phosphorylated on several tyrosine residues upon binding to
laminin 5 or activation of the EGF-R (Mainiero et al., 1995;
Mainiero et al., 1996). Tyrosine phosphorylation of 
 
 
 
4 pro-
motes recruitment of the signaling adaptor protein Shc.
Upon tyrosine phosphorylation, Shc binds to the Grb2/
mSOS complex and activates Ras and, hence, both the Raf–
extracellular signal-regulated kinase (ERK) and phosphati-
dyl inositol-3 kinase (PI-3K)-Rac-JNK signaling cascades
(Mainiero et al., 1997). Analysis of mice carrying a targeted
deletion of the 
 
 
 
4 cytoplasmic domain has indicated that
this portion of the integrin is essential for both assembly of
hemidesmosomes and activation of growth promoting sig-
naling pathways (Murgia et al., 1998). Although signaling
and assembly of hemidesmosomes by 
 
 
 
6
 
 
 
4 are temporally
distinguishable events, the relationship between the struc-
tural and signaling function of 
 
 
 
6
 
 
 
4 is currently unclear.
We have shown previously that treatment of normal kera-
tinocytes with EGF induces tyrosine phosphorylation of the
cytoplasmic domain of 
 
 
 
4 and disruption of hemidesmo-
somes (Mainiero et al., 1996). Others have suggested that
protein kinase C may play a role in this process (Rabinovitz et
al., 1999). Because the EGF-R and the 
 
 
 
6
 
 
 
4 integrin are of-
ten overexpressed in highly invasive squamous carcinomas
(Kimmel and Carey, 1986; Yamamoto et al., 1986; Tennen-
baum et al., 1996), we have examined the effect of EGF-R
activation on 
 
 
 
6
 
 
 
4 function in squamous carcinoma cells.
The results reported here indicate that a fraction of EGF-R
combines with 
 
 
 
6
 
 
 
4 and, through the tyrosine kinase Fyn,
induces phosphorylation of the 
 
 
 
4 tail and disruption of
hemidesmosomes. Inhibition of Fyn increases the assembly
or stability of hemidesmosomes and suppresses migration and
invasion by squamous carcinoma cells. These findings suggest
that the disassembly of hemidesmosomes mediated by Fyn is
a prerequisite for normal cell migration and tumor invasion.
 
Results
 
The EGF-R induces phosphorylation of 
 
 
 
4 through 
activation of a Src family kinase
 
To examine the mechanism by which the EGF-R induces
tyrosine phosphorylation of 
 
 
 
4, HaCaT keratinocytes,
MSK-QLL-1, and A431 squamous carcinoma cells were
subjected to immunoprecipitation and immunoblotting
analysis. The HaCaT keratinocytes are immortalized but re-
tain the ability to undergo differentiation in vitro (Boukamp
et al., 1988); the MSK-QLL-1 squamous carcinoma cells ex-
press normal levels of EGF-R (unpublished data), and the
A431 squamous carcinoma cells overexpress the EGF-R and
secrete high amounts of TGF-
 
 
 
 (Lin et al., 1984; Reiss et
al., 1991).
As shown in Fig. 1, treatment with EGF caused tyrosine
phosphorylation of 
 
 
 
4 in HaCaT and MSK-QLL-1 cells,
and it increased the extent to which 
 
 
 
4 was already phos-
phorylated in A431 cells. The basal phosphorylation of 
 
 
 
4
observed in A431 cells may be a consequence of the consti-
tutive activation of the EGF-R in these cells (Van de Vijver
et al., 1991). We noticed that a tyrosine phosphorylated
protein with an apparent molecular mass similar to that of
EGF-R coimmunoprecipitated with 
 
 
 
6
 
 
 
4 from both MSK–
QLL-1 and A431 cells (Fig. 1). Prolonged exposure of the
blot revealed a similar band also in 
 
 
 
4 immunoprecipitates
from HaCaT keratinocytes. Immunoblotting with specific
antibodies identified this protein as the EGF-R and pro-
vided evidence that a small but significant fraction of this re-
ceptor is associated with 
 
 
 
6
 
 
 
4 in all three cell lines (Fig. 1).
Densitometric analysis indicated that 
 
 
 
1% of total EGF-R
was coimmunoprecipitated with 
 
 
 
6
 
 
 
4 from HaCaT kerati-
nocytes and 
 
 
 
2% from the squamous carcinoma cell lines.
Control experiments indicated that neither normal mouse
IgGs nor the anti-MHC monoclonal antibody W6.32 co-
precipitated the EGF-R. Although
 
 
 
 
 
6
 
 
 
4 combines with the
EGF-R family member ErbB-2 in breast carcinoma
 
 
 
cells
which overexpress both molecules (Falcioni et al., 1997),
Figure. 1.  A fraction of EGF-R is associated with  6 4 and 
induces tyrosine phosphorylation of the  4 cytoplasmic domain. 
The indicated cells were serum starved and then treated with EGF 
(25 ng/ml, 4 min) or left untreated. After solubilization in TX-DOC 
lysis buffer, the samples were immunoprecipitated with normal 
mouse IgGs (C) or the anti- 4 monoclonal antibody 3E1 ( 4)
followed by immunoblotting with the rabbit anti– 4-exo antiserum, 
the monoclonal antibody to P-Tyr RC-20, and rabbit antibodies to 
the COOH-terminus of the EGF-R or ErbB-2. 
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and to a much smaller extent in HaCaT cells (Hintermann
et al., 2001), we were unable to detect such an association
under our experimental conditions (see Materials and meth-
ods) (Fig. 1). These results suggest that a fraction of EGF-R
associates specifically with 
 
 
 
6
 
 
 
4 and induces phosphoryla-
tion of the 
 
 
 
4 cytoplasmic domain.
Fig. 1 also shows that exposure to EGF induced limited ty-
rosine phosphorylation of the fraction of EGF-R associated
with 
 
 
 
6
 
 
 
4 in HaCaT keratinocytes. By contrast, the fraction
of EGF-R associated with 
 
 
 
6
 
 
 
4 in MSK-QLL-1 and A431
cells was constitutively phosphorylated on tyrosine, perhaps
because both cell lines secrete EGF-R ligands. Addition of
EGF induced a coordinate increase in the tyrosine phosphor-
ylation of 
 
 
 
4 and associated EGF-R in both MSK-QLL-1
and A431 cells (Fig. 1). These observations suggest that over-
expression of the EGF-R causes enhanced phosphorylation
of 
 
 
 
4 in squamous carcinoma cells. Immunofluorescence ex-
periments indicated that HaCaT and MSK-QLL-1 cells
form some hemidesmosome-like adhesions upon plating on
a laminin 5–enriched matrix in the absence of EGF. By con-
trast, A431 cells failed to assemble these adhesive junctions
under these conditions (unpublished data). Thus, increased
EGF-R–mediated phosphorylation of 
 
 
 
4 correlates with in-
hibition of hemidesmosome formation.
Because the EGF-R does not phosphorylate efficiently fu-
sion proteins derived from the cytoplasmic domain of 
 
 
 
4 in
vitro (Mainiero et al., 1997), we asked if the EGF-R pro-
motes phosphorylation of 
 
 
 
4 by activating an intermediary
kinase. It is known that the EGF-R can interact with and ac-
tivate Src family kinases (Biscardi et al., 1999). In addition,
our previous results had suggested that 
 
 
 
6
 
 
 
4 is associated
with a Src family kinase (Mainiero et al., 1995). Thus, we
examined the role of Src kinases in EGF-R–induced phos-
phorylation of 
 
 
 
4. As shown in Fig. 2 A, the two Src kinase
inhibitors, PP1 and PP2, which display a higher affinity for
Fyn than Src in vitro (Hanke et al., 1996), suppressed tyro-
sine phosphorylation of 
 
 
 
4 in HaCaT keratinocytes treated
with EGF. The effect of the two compounds was dose-
dependent and specific, as both did not interfere with the
activation and autophosphorylation of EGF-R. These results
suggest that EGF-R–induced phosphorylation of 
 
 
 
4 is me-
diated by a Src family kinase.
 
The 
 
 
 
6
 
 
 
4 integrin combines with Fyn
 
To directly test if 
 
 
 
6
 
 
 
4 associates with a Src family kinase in
vivo, we performed coimmunoprecipitation experiments.
Immunoprecipitation with a high-affinity antipeptide anti-
body reacting with the three Src family kinases, Src, Fyn,
and Yes (anti-panSrc), followed by immunoblotting with
antibodies to 
 
 
 
4, revealed that  6 4 is associated with Src
family kinases in HaCaT keratinocytes (Fig. 2 B). Treat-
ment with EGF did not modify the stoichiometry of the
complex. The coimmunoprecipitation of  6 4 and Src ki-
nases was blocked by excess of the antigenic peptide (Fig. 2
B). These results suggest that the  6 4 integrin is constitu-
tively associated with one or more Src family kinases in
HaCaT keratinocytes.
To identify the Src kinase(s) associated with  6 4, we
performed immunoprecipitation and immunoblotting ex-
periments in several epithelial cell lines. We varied extrac-
tion conditions and used antibodies reacting specifically
with Src, Fyn, or Yes, either in the immunoprecipitation or
the immunoblotting step of the coprecipitation assay. De-
spite several attempts, we were unable to detect a specific as-
sociation of Src, Fyn, or Yes with  6 4 in cells expressing
endogenous levels of Src kinases. We suspect that this nega-
tive result is due to the low stoichiometry or relative instabil-
ity of the association of  6 4 with Src kinases and the low
affinity of currently available antibodies reacting specifically
with each Src kinase.
To overcome these problems, we decided to use an overex-
pression approach. 293-T HEK cells were transfected with
vectors directing the expression of  6 4 and each one of
several cytoplasmic tyrosine kinases. Preliminary experi-
Figure 2.  A Src family kinase is associated with  6 4 and 
phosphorylates  4 in response to activation of the EGF-R. (A) After 
serum starvation, HaCaT cells were incubated for 15 min with the Src 
family kinase inhibitor PP-1 or -2 (1, 2, and 4  M), then treated with 
25 ng/ml EGF for 4 min in presence of the inhibitors. The samples 
were immunoprecipitated with the anti- 4 monoclonal antibody 3E1 
and probed by immunoblotting with the monoclonal antibody to 
P-Tyr RC-20 or the rabbit anti– 4-cyto serum. As a control, the 
samples were immunoprecipitated with the anti-EGFR monoclonal 
antibody 528 and probed by immunoblotting with the monoclonal 
antibody to P-Tyr RC-20 or the rabbit antiserum to the COOH terminus 
of the EGF-R. (B) Lysates from serum-starved HaCaT cells treated with 
EGF or left untreated (25 ng/ml, 4 min) were immunoprecipitated 
with normal rabbit IgGs (C) or the affinity-purified rabbit antibodies 
SRC2, which recognize Src, Fyn, and Yes (panSrc). The samples were 
probed by immunoblotting with rabbit anti– 4-cyto or anti-panSrc 
antibodies. The coimmunoprecipitation of  6 4 and Src kinases was 
blocked in presence of 20  g of the peptide used as antigen to gener-
ate the anti-panSrc antibodies (pep).450 The Journal of Cell Biology | Volume 155, Number 3, 2001
ments of immunoprecipitation followed by kinase assay and
V8 peptide mapping indicated that  6 4 coprecipitated
with Fyn, but to a much lesser or no extent with Src, Abl, fo-
cal adhesion kinase (FAK), or JAK1. No association of  6 1
with Fyn was detected by using the same assay (unpublished
data), suggesting that  6 4 interacts with Fyn through the
 4 subunit. 
To further examine the association of  6 4 with Src ki-
nases, 293-T cells were transfected with vectors directing the
expression of  6 4 and wild-type or mutant versions of the
Src family kinases known to be expressed in keratinocytes,
namely Fyn, Src, and Yes (Fig. 3 A). To verify that each ki-
nase was expressed at an equivalent level, we probed total ly-
sates by immunoblotting with anti-Fyn and anti-panSrc
(Fig. 3 B). Prior experiments had shown that this antibody
displays similarly high affinity for recombinant Src and Fyn
and reacts less efficiently with recombinant Yes (Fig. S1).
The transfectants were subjected to immunoprecipitation
and immunoblotting analysis. The results indicated that Fyn
and, to a somewhat more limited extent Yes, associate with
 6 4. By contrast, Src combined with  6 4 much less effi-
ciently (Fig. 3 B).
To examine the structural requirements of the interaction
of Fyn with  6 4, we introduced various mutant forms of
Fyn, in combination with wild-type  6 4 (Fig. 3 A), into
293 T cells. Immunoprecipitation and immunoblotting
analysis revealed that the association of Fyn with  6 4 was
not impaired by deletion of the SH3 domain (Fyn- SH3),
inactivation of the SH2 domain (Fyn-SH2), or impairment
of the kinase function (Fyn-K
 ) (Fig. 3 B). By contrast, mu-
tation of the two cysteine residues required for palmitoyla-
tion (Fyn-C3, 6S) reduced the association of Fyn with  6 4
considerably. Thus, we expressed a chimeric molecule com-
prising the NH2-terminus of Fyn fused to Src (Fyn1-13/
Src14-533). The Fyn–Src chimera associated with  6 4
much more efficiently than Src (Fig. 3 B). These results sug-
gest that the association of Fyn with  6 4 is not mediated
by the SH3 domain and does not require the phosphoty-
rosine binding function of the SH2 domain or the kinase ac-
tivity of the molecule. However, it requires the NH2-termi-
nal segments of Fyn, including Cys 3 and 6, which are
palmitoylated. However, palmitoylation is not the only
structural determinant required for association with  6 4,
because Lck is palmitoylated but does not combine with
 6 4. It is possible that palmitoylation promotes localiza-
tion of Fyn at the plasma membrane in close proximity to
Figure 3.  Mutational analysis of the association of Fyn with 
 6 4. (A) Structure of the Src family kinases (top) and wild-type 
and mutant  4 subunits (bottom) used to define the association 
of Fyn with  6 4. *, point mutations.  4 constructs: black boxes, 
Fn type III modules; grey box, connecting segment. (B) 293 T cells 
were transiently transfected with plasmids encoding wild-type 
 6 and  4 in combination with the indicated wild-type and 
mutant Src family kinases. After extraction in RIPA buffer, the 
lysates were immunoprecipitated with the monoclonal antibody 
3E1 covalently linked to Sepharose beads. The top part of the 
blot was probed with the rabbit antiserum  4-exo and the 
bottom with affinity purified anti-panSrc antibodies (SRC2). 
Total lysates were probed by immunoblotting with affinity-purified 
anti-Fyn (FYN3) antibodies to verify the level of expression of 
wild-type and mutant Fyn proteins (with the exception of the 
Fyn–Src chimera) and anti-panSrc (SRC2) antibodies to verify the 
level of expression of Src, the chimera Fyn–Src, and Yes; IgG H, 
immunoglobulin heavy chain. (C) 293 T cells were transiently 
transfected with plasmids encoding wild-type Fyn and  6 in 
combination with the indicated wild-type and mutant  4 subunits. 
After extraction in RIPA buffer, the lysates were immunoprecipi-
tated with the monoclonal antibody 3E1 covalently linked to 
Sepharose beads. The top part of the blot was probed with the 
rabbit antiserum  4-exo and the bottom with affinity-purified 
antibodies to Fyn (Fyn3). Total lysates were probed by immuno-
blotting with the same antibodies to verify equal expression of Fyn 
in the four samples.Fyn promotes hemidesmosome disruption and carcinoma invasion | Mariotti et al. 451
 6 4 and thereby facilitates a protein–protein interaction
between the two molecules.
To examine the sequences of  4 required for the associa-
tion with Fyn, 293 T cells were transfected with various
deletion mutants of  4 (Fig. 3 A) in combination with
wild-type Fyn. Immunoprecipitation and immunoblotting
analysis indicated that a recombinant  4 subunit lacking al-
most the entire COOH-terminal domain, which includes all
Fn-III repeats (mutant C), associated with Fyn as efficiently
as wild-type  4 (molecule A). By contrast, recombinant
forms of  4 lacking the entire (mutant L), or almost the en-
tire, cytoplasmic domain of  4 (mutant B) did not combine
with Fyn (Fig. 3 C). These observations indicate that the
membrane proximal portion of the cytoplasmic domain of
 4, comprising amino acid residues 854–1183, is required
for association with Fyn.
Taken together, these results indicate that Fyn interacts
specifically with  6 4, and that this interaction requires the
membrane-proximal NH2-terminal segment of Fyn and the
corresponding portion of the cytoplasmic domain of  4.
Fyn mediates EGF-R–induced phosphorylation of  4 
and disruption of hemidesmosomes
To examine the role of Fyn in regulation of hemidesmo-
somes, we used the rat bladder carcinoma 804G cells, which
form relatively well structured hemidesmosome-like adhe-
sions in vitro (Riddelle et al., 1991). 804G clones stably ex-
pressing a dominant negative (kinase dead) form of Fyn or a
corresponding mutant version of Src were generated. Immu-
noblotting with anti-Fyn indicated that the clones F1, 2,
and 3 express levels of kinase-dead Fyn significantly higher
than those of endogenous wild-type Fyn in control clone C1
(Fig. 4 A). Similar results were obtained with the clones S1
and 2, which express dominant negative Src (Fig. 4 A). En-
dogenous Fynand Src in clone C1 were detected only upon
overexposure of the blot. Densitometric analysis of films ex-
posed for different times indicated that kinase-dead Src and
Fyn were similarly overexpressed as compared to the levels of
corresponding wild-type endogenous proteins (unpublished
data). In addition, immunoblotting with anti-panSrc, which
reacts with Src slightly better than wth Fyn (Fig. S1), indi-
cated that kinase-dead Src was expressed at levels somewhat
higher than kinase-dead Fyn (Fig. 4 A).
To examine the role of Fyn in EGF-R–induced phosphor-
ylation of  4, clones expressing dominant negative Fyn or
Src were treated with EGF and subjected to immunoprecip-
itation with anti- 4, followed by immunoblotting with
anti–P-Tyr. As shown in Fig. 4 B, expression of dominant
negative Fyn suppressed EGF-induced tyrosine phosphory-
lation of  4, whereas dominant negative Src did not inhibit
this process. These experiments suggest that Fyn mediates
phosphorylation of  4 upon activation of the EGF-R. Src is
unable to function in this pathway presumably because it is
unable to associate efficiently with  6 4.
We next evaluated the effect of dominant negative Fyn
and Src on hemidesmosomes. At the immunofluorescent
microscope, hemidesmosomes appear as punctuate struc-
tures, which tend to coalesce around circular areas of un-
known composition. The resulting staining is commonly re-
ferred to as “swiss cheese”–like. As shown in Fig. 5, staining
with antibodies to BPAG-2 revealed that 804G clones ex-
pressing dominant negative Fyn display a significantly
higher number of hemidesmosomes than control cells. The
Figure 4.  Dominant negative Fyn, but not Src, suppresses EGF-
mediated tyrosine phosphorylation of  4. (A) Total lysates of 804G 
clones stably transfected with empty vector (C1) or dominant 
negative Fyn (F1, 2, and 3) were probed by immunoblotting with 
affinity purified anti-Fyn (FYN3) or anti-panSrc antibodies (SRC2). 
Total lysates of 804G clones stably transfected with empty vector 
(C1) or dominant negative Src (S1 and 2) were probed by immunob-
lotting with affinity purified anti-Src (N-16) or anti-panSrc antibodies 
(SRC2). (B) After serum starvation, the indicated 804G clones were 
treated with 50 ng/ml EGF for 5 min or left untreated. The lysates 
were immunoprecipitated with the rabbit antiserum  4 cyto and 
probed by immunoblotting with the anti–P-Tyr monoclonal 
antibody RC-20 or the rabbit antiserum  4 cyto.
Figure 5.  Dominant negative Fyn promotes assembly and/or 
inhibits disassembly of hemidesmosomes. The indicated 804G 
clones were plated on glass coverslips for 24 h and then treated for 
12 h with 50 ng/ml EGF in serum-free medium or left untreated. 
After a mild extraction with Triton X-100, the cells were fixed and 
stained with affinity purified antibodies to BPAG-2 to visualize 
hemidesmosomal structures. Results similar to those shown here 
were obtained with all three clones expressing dominant negative 
Fyn and the two clones expressing dominant negative Src.452 The Journal of Cell Biology | Volume 155, Number 3, 2001
clones expressing dominant negative Src did not have an in-
creased number of hemidesmosomes; however, these junc-
tions tended to be somewhat more clustered than in control
cells. Similar results were obtained after staining with anti-
bodies to  4 (unpublished data). Treatment with EGF
caused an almost complete disruption of hemidesmosomes
in control cells and clones expressing dominant negative Src.
By contrast, the hemidesmosomes of clones expressing dom-
inant negative Fyn were resistant to the effect of EGF to a
significant extent (Fig. 5). Parental 804G cells and HaCaT
keratinocytes treated with PP2 displayed a similar stabiliza-
tion of hemidesmosomes (unpublished data). These results
imply that Fyn prevents the assembly and/or causes disas-
sembly of hemidesmosomes and this effect requires the cata-
lytic activity of the kinase.
Src kinases are required for migration and invasion
It is reasonable to assume that a cell must disassemble stable
adhesions with the extracellular matrix, such as hemidesmo-
somes, in order to migrate and invade (Giancotti and Main-
iero, 1994). Thus, we examined if inhibition of Fyn sup-
pressed cell migration. As shown in Fig. 6, 804G clones
expressing dominant negative Fyn migrated across an artifi-
cial in vitro wound much less efficiently than control clones.
The migratory ability of clones expressing dominant nega-
tive Src was also reduced, but to a lesser extent than that of
clones expressing dominant negative Fyn. This effect of
dominant negative Src may result from stabilization of focal
adhesions (Fincham and Frame, 1998). Immunofluorescent
staining with antibodies to BPAG-2 revealed disassembly of
hemidesmosomes at the rear end of control cells entering the
wound area. Similar results were obtained with cells express-
ing dominant negative Src. By contrast, these posterior
hemidesmosomes were not disassembled in cells expressing
dominant negative Fyn (Fig. 6). These observations suggest
that dominant negative Fyn inhibits cell migration by en-
hancing the stability of hemidesmosomes.
We next used chemical inhibitors to examine the role of Src
kinases in cell invasion through the reconstituted basement
membrane Matrigel. As shown in Fig. 7, the Src kinase inhibi-
tors Herbimycin and PP2 inhibited Matrigel invasion by A431
and MSK-QLL-1 squamous carcinoma cells. The effect of these
two inhibitors was comparable or superior to that of the PI-3K
inhibitor LY294002, which previous studies have shown to
profoundly affect tumor invasion in vitro (Keely et al., 1997).
In contrast, an inihibitor of the p38 MAP kinase did not exert a
significant effect on Matrigel invasion by these cells.
Inhibition of Fyn suppresses experimental
metastasis formation
The 804G cells did not produce lung metastases upon intra-
venous injection in nude mice (unpublished data). To test
the role of Fyn in squamous carcinoma metastasis, we gener-
ated A431 clones expressing dominant negative Fyn. These
clones grew in culture at the same rate of control cells and
did not undergo apoptosis when maintained in suspension
for 24 h (unpublished data). In addition, they continued to
proliferate in suspension at the same rate of control cells, as
shown by the presence of similar number of mitotic figures
Figure 6.  Dominant negative Fyn inhibits 
disassembly of hemidesmosomes and suppresses 
cell migration. The indicated 804G clones were 
grown until confluent and then serum starved. 
After wounding, the monolayers were treated with 
EGF (50 ng/ml) for 5 or 10 h or left untreated for
5 h, and then either stained with Crystal violet or 
subjected to immunofluorescent staining with 
affinity purified anti–BPAG-2 antibodies. Cell 
migration results were quantitated as described in 
the Materials and methods section and plotted 
graphically. The graph shows the mean and SD of 
values from a representative experiment performed 
in triplicate. Results similar to those shown here 
were obtained with all three clones expressing 
dominant negative Fyn and the two clones 
expressing dominant negative Src. Bar, 250  m.
Figure 7.  Src-family kinases are required for squamous carcinoma 
invasion through Matrigel. A431 and MSK-QLL-1 cells were plated 
on Matrigel together with the Src family kinase inhibitors Herbimy-
cin A (100 ng/ml) and PP-2 (1, 5, and 10  M), the PI-3K inhibitor 
LY294002 (25  M), or the p38 kinase inhibitor SB203580 (10  M). 
Serum-free medium containing EGF (25 ng/ml) was added to the 
lower chamber. After 24 h, cells that had invaded through Matrigel 
and remained attached to the lower side of the filter were stained 
with Crystal violet and counted under a microscope. The graphs 
show the mean and SD of values from a representative experiment 
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after 24 h of suspension culture (unpublished data). These
results suggest that dominant negative Fyn does not inhibit
growth or survival of A431 cells.
Next, we sought to verify that dominant negative Fyn
prevented tyrosine phosphorylation of  4 and stabilized
hemidesmosomes also in A431 cells. As shown in Fig. 8 A,
EGF treatment caused significant tyrosine phosphorylation
of  4 in the control clone, but not in those expressing dom-
inant negative Fyn. In addition, whereas A431 clones ex-
pressing dominant negative Fyn were able to form numerous
hemidesmosome-like adhesions upon plating on a laminin 5
matrix, control cells were much less able to do so (Fig. 8 B).
Finally, clones expressing dominant negative Fyn migrated
into an artificial wound and invaded through Matrigel less
efficiently than control clones (Fig. 8 C). These results indi-
cate that dominant negative Fyn stabilizes hemidesmosomes
and suppresses migration and Matrigel invasion by A431
squamous carcinoma cells.
Intravenous injection of control A431 cells in nude mice
resulted in the appearance of lung metastases within 5 wk.
Histologically, these metastases appeared as large, often bilat-
eral nodules occupying a significant area of lung parenchyma
(Fig. 8 D). They were often necrotic in the center. Their
identity as lung metastasis of A431 cells was confirmed by
immunostaining with antibodies to  4 and keratins 5 and
14 (unpublished data). We evaluated the number of lung
metastases formed by A431 clones expressing dominant neg-
ative Fyn and control clones by histological analysis of serial
sections spanning the entire lungs of each injected mouse.
The results indicated that A431 cells expressing dominant
negative Fyn have a considerably reduced ability to colonize
the lung upon intravenous injection in nude mice (Fig. 8 C
and D). This observation implies that inhibition of Fyn im-
pairs squamous carcinoma invasion in vivo.
Discussion
It is likely that changes in integrin expression facilitate tu-
mor invasion because of their combined effects on cell adhe-
sion and signaling (Giancotti and Mainiero, 1994; Varner
and Cheresh, 1996; Boudreau and Bissell, 1998). The  6 4
integrin is expressed at higher levels in squamous carcinomas
of the skin, larynx, cervix, and lung than in corresponding
normal tissues (Kimmel and Carey, 1986; Costantini et al.,
1990). In addition, whereas normal thyroid epithelium does
not express  6 4, the integrin appears to be present at sig-
nificant levels on the surface of a large proportion of thyroid
carcinomas (Serini et al., 1996). Several studies suggest that
 6 4 facilitates tumor invasion (Wolf et al., 1990; Carico et
al., 1993; Tani et al., 1996; Shaw et al., 1997). If this is true,
a mechanism must exist to inactivate the ability of  6 4 to
mediate stable adhesion to the basement membrane. Our re-
sults indicate that a fraction of EGF-R combines with  6 4
and, through the integrin-associated Src family kinase Fyn,
induces tyrosine phosphorylation of the  4 cytoplasmic do-
main and disruption of hemidesmosomes. Dominant nega-
tive Fyn, but not Src, stabilizes hemidesmosomes and pre-
vents their disassembly in response to EGF. Accordingly,
carcinoma cells expressing dominant negative Fyn migrate
and invade in vitro much less than control cells and are un-
able to form lung metastases upon injection in the tail vein
of nude mice. These findings identify a mechanism of
hemidesmosome disassembly important for both normal cell
migration and carcinoma invasion.
Previous studies have indicated that cell migration and in-
vasion require assembly of focal adhesions and stress fibers at
the leading edge of the cell and their disassembly at the trail-
ing edge (Horwitz and Parsons, 1999). These processes are
jointly regulated by  1 and  v integrins and by growth fac-
tor receptors through the focal adhesion kinase FAK (Sieg et
al., 2000) and the adaptor protein Shc (Collins et al., 1999;
Gu et al., 1999). Upon activation, FAK combines with Src,
which phosphorylates a number of focal adhesion compo-
nents, including p130
CAS and paxillin (Giancotti and Ruo-
Figure 8.  Dominant negative Fyn restores hemidesmosomes and 
inhibits both Matrigel invasion and experimental metastasis in 
A431 cells. (A) Two A431 clones expressing dominant negative Fyn 
(F35 and F25) and a control clone (C1) were starved and then 
treated with EGF (25 ng/ml) for 10 min or left untreated. RIPA 
lysates were immunoprecipitated with the anti- 4 monoclonal 
antibody 3E1 and probed by immunoblotting with the anti–P-Tyr 
monoclonal antibody RC-20 or the rabbit antiserum  4 cyto. The 
indicated A431 clones were plated on laminin 5 matrix–coated 
glass coverslips for 48 h. Cells were mildly permeabilized with 
Triton X-100, fixed, and stained with the anti- 4 monoclonal anti-
body 3E1. (C) The indicated A431 clones were tested for their 
ability to migrate in an in vitro wound assay, to invade through 
Matrigel in response to EGF (25 ng/ml) as described in the legends 
to Figs. 6 and 7, and to form lung metastases upon injection in the 
tail vein of nude mice. The number of metastatic over total number 
of lungs examined is shown at the top of each bar. (D) Hematoxylin 
and eosin staining of lung sections from mice injected with C1 or 
F25 cells. The arrows point to a large and a smaller lung metastasis 
in a mouse injected with C1 cells; no metastases are visible in the 
lung section from a mouse injected with F25 cells. Bar, 500  m.454 The Journal of Cell Biology | Volume 155, Number 3, 2001
slahti, 1999). Genetic evidence implies that Src signaling
stimulates cell migration by promoting spreading of the
leading edge and turnover of focal adhesions at the trailing
edge (Kaplan et al., 1995; Fincham and Frame, 1998; Kling-
hoffer et al., 1999). Shc is activated by Fyn and possibly
other palmitoylated Src family kinases (Wary et al., 1998)
and plays a role in cell migration through activation of ERK
and disassembly of focal adhesions (Collins et al., 1999; Gu
et al., 1999). In addition to, or instead of, focal adhesions,
many epithelial cells form hemidesmosomes. Our results ar-
gue that their disassembly in response to activation of the
EGF-R and phosphorylation of the  4 tail is required for
epithelial cell migration and invasion.
What is the mechanism by which EGF causes phosphory-
lation of the  4 cytoplasmic domain? Our results indicate
that a fraction of EGF-R associates with  6 4 and induces
phosphorylation of the  4 cytoplasmic domain through the
Src family kinase Fyn (Fig. 9). Dominant negative studies
suggest that Src can not replace Fyn in this pathway. This is
most likely because Fyn combines with  6 4, but Src does
so much less efficiently. By contrast, Yes combines relatively
efficiently with  6 4. The NH2-terminal domains of both
Fyn and Yes are known to be palmitoylated and we have ob-
served that the association of Fyn with  6 4 requires this
lipid modification. It is likely that the association of Yes with
 6 4 similarly requires palmitoylation of the kinase.
Previous studies have indicated that palmitoylation targets
Fyn and other signaling molecules to defined membrane mi-
crodomains enriched in cholesterol and glycosphingolipids
(membrane rafts) (van’t Hof and Resh, 1997; Brown and
London, 1998). Increasing evidence suggests that targeting
of signaling molecules to membrane rafts promotes com-
partmentalization of signaling complexes, thus ensuring sig-
naling specificity. A prime example is provided by the T cell
receptor. Upon T cell receptor activation, its   chains accu-
mulate in membrane rafts, where they interact with Fyn and
other signaling molecules (Baldari et al., 2000). Palmitoyla-
tion of Fyn is required to localize the kinase to rafts, where it
phosphorylates the   chain immunoreceptor tyrosine-based
activation motifs (ITAMs). The SH2 domain of Fyn then
combines with the phosphorylated ITAMs stabilizing the in-
teraction with the   chain (van’t Hof and Resh, 1999). In-
terestingly, we have recently observed that a significant frac-
tion of  6 4 is palmitoylated and localized to membrane
rafts (unpublished data). It is possible that palmitoylation of
 6 4 mediates localization to membrane rafts thus facilitat-
ing interaction with Fyn (Fig. 9).
Our mutagenesis results indicate that the association of
 6 4 with Fyn requires the membrane proximal segment of
the cytoplasmic domain of  4, but not the SH2 domain, the
SH3 domain, or the enzymatic function of Fyn, suggesting
that palmitoylation of  6 4 and Fyn may be required but not
sufficient to mediate the interaction between the two mole-
cules. It is likely that the membrane proximal portion of the
cytoplasmic domain of  4 and the NH2-terminus of Fyn es-
tablish a protein–protein interaction. However, future studies
will be required to identify more precisely the protein se-
quences involved in this interaction. In addition, although our
data are most consistent with the hypothesis that Fyn interacts
with and phosphorylates  4 directly, this remains to be estab-
lished formally.
The cytoplasmic domain of  4 has both a signaling and a
cytoskeletal function. What is the relationship between these
two functions? Ligation of  6 4 causes a rapid phosphoryla-
tion of the  4 tail, followed by recruitment of Shc and activa-
tion of ERK (Mainiero et al., 1995, 1997). In addition, there
is evidence that  6 4 activates PI-3K, either through Ras or
IRS-1 and 2, rapidly (Mainiero et al., 1997; Shaw et al.,
1997; Shaw, 2001). Finally, our results suggest that the EGF-
R can activate  6 4 signaling, by acting on Fyn, with a simi-
larly rapid kinetics. By contrast, assembly of hemidesmo-
somes is a much slower process, at least in cultured cells
(Riddelle et al., 1991). In addition, because exposure to EGF
induces both phosphorylation of  4 and disruption of
hemidesmosomes, it is likely that  6 4-dependent signaling
and nucleation of hemidesmosomes are mutually exclusive
processes. It is possible that phosphorylation of  4 by Fyn
prevents incorporation of  6 4 in hemidesmosomes (Fig. 9).
Previous studies have indicated that mutation of the four
tyrosine residues in  4 necessary for binding to Shc prevents
disassembly of hemidesmosomes in cells exposed to the tyro-
sine phosphatase inhibitor pervanadate (Dans et al., 2001).
However, this mutation does not interfere with hemidesmo-
some disruption in response to EGF in both 804G cells
(Dans et al., 2001), and in keratinocytes (unpublished data).
It is possible that EGF prevents assembly of hemidesmo-
somes by promoting phosphorylation of additional tyrosine
residues, as suggested by the fact that mutation of the four
tyrosines necessary for binding to Shc reduces but does not
suppress tyrosine phosphorylation of  4 in response to EGF
(unpublished data). In addition, it is known that the EGF-R
activates PKC through PLC-  (Chen et al., 1996), and there
is evidence suggesting that inhibition of PKC prevents EGF-
Figure 9.  Relationship between  6 4 signaling and assembly of 
hemidesmosomes. Hypothetical model of the underlying pathways. 
We have observed that the palmitoylated fraction of  6 4 is 
localized in lipid rafts and is preferentially associated with Fyn 
and Yes (unpublished data). We hypothesize that this fraction of 
 6 4 mediates recruitment of Shc and activation of Ras and PI-3K. 
The EGF-R induces  6 4 signaling by activating Fyn and Yes and 
causing phosphorylation of the  4 cytoplasmic domain. It is likely 
that the signaling fraction of  6 4 exists in dynamic equilibrium with 
the cytoskeletal fraction involved in assembly of hemidesmosomes. 
We hypothesize that assembly of hemidesmosomes requires 
dephosphorylation of the  4 tail (Dans et al., 2001).Fyn promotes hemidesmosome disruption and carcinoma invasion | Mariotti et al. 455
mediated disruption of hemidesmosomes (Rabinovitz et al.,
1999). Thus, it is also possible that PKC contributes to dis-
ruption of hemidesmosomes by phosphorylating the  4 tail
on serine residues (Rabinovitz et al., 1999) or by contribut-
ing to the activation of Fyn (Shanmugam et al., 1998). Fi-
nally, although we did not detect tyrosine phosphorylation
of BPAG-1 or -2, or plectin/HD-1 in cells treated with EGF
(unpublished data), activation of the EGF-R could affect the
function of other hemidesmosomal components or the sta-
bility of other interactions within hemidesmosomes.
Introduction of  6 4 in breast carcinoma cells that have
lost its expression promotes activation of the PI-3K–Rac
pathway and invasion through Matrigel (Shaw et al., 1997).
Because it is well established that PI-3K–Rac signaling is im-
portant for tumor invasion (Keely et al., 1997), it is possible
that, in addition to promoting disruption of hemidesmo-
somes and thus releasing the cell’s brakes,  6 4-associated
Fyn promotes migration and invasion by activating the PI-
3K–Rac pathway or signaling to ERK (Fig. 9).
In squamous carcinoma cells, the fraction of EGF-R asso-
ciated with  6 4 appears to be activated even in the absence
of exogenous EGF. Hence, these cells display enhanced tyro-
sine phosphorylation of  4 and reduced ability to assemble
hemidesmosomes. These observations imply that the signal-
ing pathway that prevents assembly of hemidesmosomes is
constitutively activated in squamous carcinoma cells. Domi-
nant negative Fyn suppresses the ability of these cells to mi-
grate and invade both in vitro and in vivo suggesting that
disruption of hemidesmosomes is required for carcinoma in-
vasion. Because in our experimental metastasis assay the cells
were injected directly into the blood stream, Fyn is probably
required in one or more steps of the extravasation process,
perhaps traversal of the endothelial basement membrane
and/or underlying interstitial matrix. To our knowledge, our
study provides the first evidence that inhibition of a Src fam-
ily kinase suppresses a complex phenomenon such as me-
tastasis. It is plausible that strategies aimed at inhibiting the
kinase activity of Fyn may be useful to control squamous
carcinoma progression.
Materials and methods
Cell culture and DNA constructs
The immortalized human keratinocytes HaCaT (Boukamp et al., 1988), epi-
dermoid squamous carcinoma cells A431 (from American Type Culture
Collection) and MSK-QLL-1 (Xu et al., 1994), human embryonic kidney
cells 293-T, provided by D. Levy (New York University School of Medicine,
New York, NY), rat bladder carcinoma cells 804G (Izumi et al., 1981), and
mouse mammary carcinoma cells RAC-11P/SD (Sonnenberg et al., 1993)
were cultured in DME supplemented with 10% fetal bovine serum (Sigma-
Aldrich). 293-T cells were transiently transfected by using the calcium
coprecipitation method and lysed 24 h later. A431 and 804G cells were
transfected with Lipofectamine (GIBCO BRL) according to the manufacturer’s
instructions. Transfected cells were selected in Hygromycin B (Calbiochem).
All eucaryotic expression vectors were based on the cytomegalovirus pro-
moter. Vectors encoding human  6,  4,  4 deletion mutants (B, C, L), Src,
Fyn, Fyn  SH3, kinase-dead Fyn or Src, and the palmitoylation-defective
Fyn mutant (FynC3,6S) have been described previously (Spinardi et al.,
1993; Alland et al., 1994; Mainiero et al., 1997; Wary et al., 1998). The vec-
tor encoding Yes was provided by M. Sudol (Mount Sinai Medical School,
New York, NY). The Fyn-SH2 point mutant (FynR176E) was generated by
two-step PCR using the oligonucleotides 5 -ACCTTGCGTACGAGAGGA,
5’-TCACTCTCTTCGATAAGAAAG, 5 -TTTCTT-ATCGAAGAGAGTGAA,
and 5 GATTCTCGAGGGATTTCCCAG; the PCR product was cloned into
the SplI/XhoI sites of pRK5-c-Fyn. The chimera Fyn–Src (Fyn1-13/Src14-533)
was generated by PCR with the oligonucleotides 5 -ATCGGATCC-
GGAAATTTTGGAATTTAG and 5 -ATGCCGGCGTTTTGTTGCTTCTTTAT;
the PCR product was cloned into the HindIII/NaeI site of pRK5-c-Src.
Antibodies and chemical compounds
The monoclonal antibody 3E1, reacting with the extracellular portion of
human  4, and the rabbit polyclonal antiserum to the COOH-terminal
peptide of  4, have been described previously (Giancotti et al., 1992). The
rabbit polyclonal antiserum to the COOH-terminal of the EGF receptor
was obtained from J. Schlessinger (New York University School of Medi-
cine, New York, NY). The affinity- purified rabbit polyclonal antibodies to
Fyn (FYN3), Src (N-16), Src kinases (anti-pan Src SRC2), and ErbB-2 (C-18),
and the mouse monoclonal antibody to the EGF-R (528) were from Santa
Cruz Biotechnology, Inc. The anti-phosphotyrosine monoclonal antibody
RC20 was from BD Transduction Laboratories. The rabbit antiserum  4-
exo, reacting with the extracellular portion of  4, and affinity-purified rab-
bit antibodies to BPAG2 have been described previously (Murgia et al.,
1998). The Src kinase inhibitors PP1, PP2 (Calbiochem), and Herbimycin
A (GIBCO BRL), the PI-3K inhibitor LY 294002 (Biomol), and the p38 ki-
nase inhibitor SB203580 (Stratagene) were dissolved in DMSO and further
diluted in culture medium.
Biochemical methods
Prior to treatment with EGF (25 ng/ml, 4 min) (Intergen), HaCaT and MSK-
QLL-1 cells were serum starved overnight; A431 cells were starved for 40 h.
The cells were then lysed in TX-DOC lysis buffer (50 mM Hepes, 150 mM
NaCl, 4 mM EDTA, 1 mM EGTA, 1% Triton X-100, and 0.5% sodium
deoxycolate) containing 1 mM sodium orthovanadate, 20 mM sodium py-
rophosphate, 100 mM NaF, 0.02% aprotinin, 20  g/ml leupeptin, and 4
 g/ml pepstatin A (all from Sigma-Aldrich). 804G cells were stimulated
with 50 ng/ml EGF for 4 min and lysed in modified RIPA buffer (50 mM
Hepes, 150 mM NaCl, 4 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton
X-100, 1% sodium deoxycolate, and 0.1% sodium dodecylsulfate) con-
taining protease and phosphatase inhibitors as above. 293-T cells were
lysed in modified RIPA buffer. The Src family kinase inhibitors PP1 and
PP2 were added to the culture medium at the indicated concentrations,
and cells were incubated for 15 min at 37 C before the addition of EGF.
Immunoprecipitation and immunoblotting were performed as described
previously (Mainiero et al., 1995). To avoid aspecific binding of the EGF-R
to the beads during immunoprecipitation experiments, cell lysates were
precleared with protein A Agarose (Upstate Biotechnology) and normal
Mouse IgGs (Sigma-Aldrich) covalently linked to CNBr-activated Sepha-
rose™ 4B (Amersham Pharmacia Biotech) for 1.5 h at 4 C. After centrifu-
gation, the supernatants were immunoprecipitated using the 3E1
monoclonal antibody covalently linked to CNBr-activated beads. The im-
mobilized immunocomplexes were washed extensively in lysis buffer be-
fore SDS-PAGE. To cross-link the antibodies to the Sepharose beads, the
antibodies were dialyzed in Spectra/Por MWCO:6–8,000 dialysis bags
(Spectrum Medical Industries) against coupling buffer (carbonate-bicar-
bonate buffer, pH 9.2, 0.5 M NaCl) overnight at 4 C. CNBr-activated Seph-
arose beads (400 mg/5 mg of antibody) were incubated in 1 mM HCl for
15 min at room temperature. The beads were then washed with 1 mM HCl
and then once in coupling buffer before incubation with the antibody. The
suspension was incubated overnight at 4 C on a rotator, then spun down,
and the pellet was washed two times in 0.1 M Tris HC, pH 8, containing
0.5 M NaCl, and stored in TBS at 4 C. The efficiency of cross-linking was
checked by measuring the concentration of the dialyzed antibody before
and after incubation with the activated beads. This method allows to mini-
mize the amount of beads used (about 10  l/sample) and to use high quan-
tities of antibody (25–30  g/sample).
Immunofluorescence
804G clones were plated on glass coverslips for 24 h and then treated with
EGF (50 ng/ml) in serum-free medium. The cells were permeabilized in
0.2% Triton X-100 in PBS for 4 min on ice and fixed with cold methanol
for 10 min. A431 clones were plated on glass coverslips coated with the
laminin 5 matrix deposited by RAC-11P/SD cells (Sonnenberg et al., 1993)
for 48 h before permeabilization and fixation. The cells were incubated for
1 h with the primary antibody, washed with 0.1% Triton X-100 in PBS, and
then stained with FITC-conjugated goat anti–mouse or goat anti–rabbit
IgGs (Jackson ImmunoResearch Laboratories) for 45 min. After washing,
the coverslips were mounted in Citifluor mounting medium (Ted Pella).
In vitro wound assay and invasion assay
After overnight starvation, wounds were made on confluent cell monolay-
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or 10 h, and A431 cells were treated with EGF (25 ng/ml) for 24 h, before
staining in 0.25% crystal violet. To quantify cell migration, three randomly
chosen regions of a wound (1 mm long) were photographed at a magnifi-
cation of 40X; a mean wound width was measured every 20  m, and an
average percent wound closure was calculated. Three independent
wounds were examined per sample and a mean percent wound closure
was calculated.
For in vitro invasion assays, 50  l of Matrigel (Collaborative Biomedical
Products) (1 mg/ml in serum-free DME) was allowed to gelify on the upper
side of the filter (8  m pore size) in a Transwell chamber (Corning Costar
Corp.) at 37 C for 2 h. Cells were then plated on the Matrigel (80,000 cells
per chamber in 100  l of serum-free DME), let attach for 2 h, and the
lower chamber was filled with serum-free medium containing EGF (25 ng/
ml). After 24 h, the Matrigel and the cells that did not invade were re-
moved from the upper side of the filter with a cotton swab, and the cells at-
tached to the lower side of the filter were stained with crystal violet and
counted. Each experiment was performed in triplicate. For invasion assays
in presence of chemical inhibitors, cells were seeded on Matrigel and,
when attached, the indicated compound was added to the medium. The
inhibitor was present in the upper chamber for the entire duration of the
assay; at the end of the assay, cell viability in the upper chamber was as-
sessed by Trypan blue.
In vivo metastasis formation experiment
3–6-wk-old athymic nude mice (Nu/nu Harlan Sprague Dawley) were in-
jected with 2   10
6 cells suspended in 200  l of PBS. After 5 wk, the mice
were sacrificed and their lungs removed, fixed in formalin, and paraffin-
embedded. 8- m sections were stained with Gill’s hematoxylin and eosin,
and examined for the presence of lung metastases.
Online supplemental material
Fig. S1 is available at http://www.jcb.org/cgi/content/full/jcb.200105017/
DC1 and shows reactivity of the anti-pan Src antibodies with recombinant
Fyn, Src, and Yes.
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